Introduction
============

Acute kidney injury (AKI) is a frequent complication of cardiac surgery and renal replacement therapy (RRT) is required in 1 to 4% of the cases \[[@B1]-[@B6]\]. Such severe AKI has been shown to be independently associated with increased in-hospital mortality \[[@B7]\].

The pathophysiology of cardiac surgery-associated AKI is still poorly understood. A decrease in renal blood flow (RBF) is believed to play a pivotal role in its pathogenesis \[[@B8],[@B9]\]. There are, however, only very limited human data supporting this concept. Indeed, RBF \[[@B10]\] measurement, irrespective of the technique used, has only been reported in 46 critically ill patients (five studies) within the last sixty years. Thus, our knowledge, understanding, and theoretical constructs regarding renal perfusion in critically ill patients are based on extremely weak direct evidence.

Furthermore, given the complex and heterogeneous nature of the renal vasculature, some pathophysiological processes might be associated with increased global RBF \[[@B11],[@B12]\] despite loss of function suggesting intra-renal shunting \[[@B13]\]. Therefore, techniques allowing the study of microcirculatory parameters might be more valuable in increasing our understanding of the pathophysiology of AKI. Such parameters can be evaluated by a relatively recent imaging technique, renal contrast-enhanced ultrasonography (CEUS). However, CEUS is still used infrequently in clinical practice. In particular, there are no data on the feasibility, safety, reproducibility and diagnostic value of CEUS in critically ill patients. We hypothesized that CEUS would be safe and feasible and allow quantification of changes in the renal cortical microcirculation in patients undergoing cardiac surgery.

Methods
=======

The study was approved by the Austin Health Research Ethics Committee (H2010/03798).

Study protocol
--------------

We approached 12 patients planned for elective cardiac surgery and obtained informed consent. We restricted inclusion to patients deemed at high risk of AKI \[[@B14],[@B15]\]. We therefore included only patients fulfilling one or more of the following criteria: age above 70 years, preexisting renal impairment (pre-operative plasma creatinine concentration \>120 μmol/l), New York Heart Association (NYHA) class III/IV or impaired left ventricular function defined as left ventricular ejection fraction (LVEF) \<35%, valvular surgery, redo cardiac surgery or insulin-dependent type 2 diabetes mellitus.

We excluded patients with intolerance to Sonovue^®^(Bracco, Milano, Italy) or any other ultrasound contrast agent, end stage renal disease (plasma creatinine concentration \>300 μmol/l or on haemodialysis, emergency cardiac surgery, planned off-pump cardiac surgery, known blood-borne infectious diseases, inability to obtain informed consent or enrolment in a conflicting research study. For each study patient, we performed renal CEUS on three occasions: before the surgical procedure (baseline), on ICU admission and the day after the operation.

Ultrasound equipment and settings
---------------------------------

We performed all measurements using an IU22^®^ultrasound system (Philips, Amsterdam, Netherlands) with a C5-1 probe (1 to 5 MHz). We used contrast-specific mode with a low mechanical index (MI: 0.06) (R1). We set gain and depth for each patient during baseline and kept them constant for all further measurements.

We used Sonovue^®^as the contrast agent. The agent was administered as continuous infusion at a rate of 1 ml/min using a VueJect™ syringe pump (Bracco Research, Geneva, Switzerland). After the start of the infusion, we allowed a 2-minute equilibration period and then performed and recorded five destruction-reperfusion sequences. We achieved contrast microbubble destruction by applying five pulses at high MI (flash: MI 1.24) and observed refilling at low MI (15 seconds total refilling time). We ascertained full destruction of contrast agent in the scan plane before performing destruction-reperfusion sequences.

For further examinations, to ensure that a similar portion of the renal cortex was examined, we used anatomical landmarks and visually compared the image with previously acquired sequences.

Data analyses
-------------

We exported destruction-reperfusion sequences in digital imaging and communication in medicine (DICOM) format and analysed them using dedicated software (Sonotumor™, Bracco Research, Geneva, Switzerland). These analyses were performed by two independent radiologists (MG and TS) blinded to patient and time. In order to compensate for minor breathing artefacts, all sequences were applied with motion compensation prior to the start of the analyses.

For each sequence, one region of interest (ROI) was drawn. In order to minimize the influence of local perfusion heterogeneities, this ROI was drawn so that it enclosed all visible renal cortex on the surface of the kidney closest to the ultrasound probe. Cortex that was only intermittently visible because of breathing or other artefacts was not included in the ROI.

The software generates a perfusion index (PI), which is thought to be proportional to perfusion within an ROI. Such a PI is calculated by dividing the relative blood volume (RBV) by the mean transit time (mTT) and is expressed in arbitrary units (a.u.). These parameters have been described in detail elsewhere \[[@B16],[@B17]\]. In brief, the RBV is a measure of pixel luminance and is proportional to contrast agent concentration within an ROI (it increases with higher levels of perfusion). The mTT is a measure of the time to replenishment after flash destruction of the contrast agent (it decreases with higher levels of perfusion).

For each patient and study time, the median value for the five measurements was considered for analysis. Suboptimal sequences with inadequate insonification or excessive breathing artefact were excluded as evaluated by both readers. In case of disagreement on sequence exclusion, the two readers reviewed the sequences simultaneously and consensus was reached.

Safety parameters
-----------------

For baseline studies we performed non-invasive haemodynamic (cardiac rhythm, non-invasive blood pressure and pulse oximetry) monitoring during contrast-agent infusion and for the subsequent 30 minutes. For post-operative studies full haemodynamic monitoring including invasive arterial blood pressure, pulmonary artery pressures, and cardiac index (via pulmonary artery catheter) was available for all patients.

Statistical analysis
--------------------

Analysis was performed using SAS version 9.2 (SAS Institute Inc., Cary, NC, USA). All outcomes were assessed for normality and as RBV, mTT and PI were all well-approximated by log-normal distributions, each was log-transformed prior to analysis. Inter-observer agreement was determined using correlation analyses as well as intra-class correlation \[[@B18]\]. For both tests, values ranged from 0 to 1 (0: absence of correlation, 1: perfect correlation). They were reported using a Bland-Altman plot with 95% limits of agreement.

Descriptive results are reported as mean (SD) for normally distributed data, otherwise as median (IQR). Longitudinal analysis determining changes from baseline was performed using mixed linear modelling with each patient treated as a random effect. Multivariable models were constructed considering all available haemodynamic and biological parameters (mean arterial pressure, cardiac index, vasoconstrictor infusion, lactate serum level, arterial pH, and serum haemoglobin level) with statistically significant variables included in the final models. A two-sided *P*-value of 0.05 was considered to be statistically significant.

Results
=======

Patients\' description and outcomes
-----------------------------------

Characteristics of the twelve patients are presented in Table [1](#T1){ref-type="table"}. The procedure was coronary artery graft surgery (CAGS) in six patients, valvular replacement surgery (including double-valve surgery) in three and a combination of CAGS and valvular surgery in three patients. Median length of stay in hospital was 11 (8.0 to 16.5) days. All patients survived to hospital discharge.

###### 

Patients\' characteristics

  Patient number   Body weight, Kg   Operation    CPB duration   LVEF    APACHE III score   VasoC   Diuretics   Baseline GFR, ml/min^a^   RIFLE score   Hospital length of stay, days
  ---------------- ----------------- ------------ -------------- ------- ------------------ ------- ----------- ------------------------- ------------- -------------------------------
  1                123               CABG         79             \>60%   48                 N       Y           142                       I             8
  2                101               CABG         104            \>60%   36                 Y       N           87                        0             7
  3                107               AVR + CABG   207            40%     45                 Y       N           152                       R             7
  4                80                MVR          130            \>60%   38                 Y       N           98                        0             32
  5                76                AVR + CABG   226            20%     68                 Y       Y           47                        R             62
  6                83                MVR + TVR    119            \>60%   59                 Y       Y           47                        0             8
  7                81                CABG         86             \>60%   40                 N       N           59                        0             8
  8                78                AVR          114            40%     32                 N       N           120                       0             15
  9                81                CABG         69             40%     71                 Y       N           59                        0             15
  10               78                CABG         No CPB         \>60%   54                 N       N           113                       0             11
  11               79                CABG         90             \>60%   56                 Y       N           52                        0             11
  12               106               AVR + CABG   151            \>60%   74                 Y       Y           86                        R             18

^a^Calculated with the Cockroft-Gault equation. CPB, cardiopulmonary bypass; CABG, coronary arteries bypass graft; AVR, aortic valve replacement; MVR, mitral valve replacement; TVR, tricuspid valve replacement; LVEF, left ventricular ejection fraction; APACHE, Acute Physiology and Chronic Health Evaluation; RIFLE: risk, injury, failure, loss and end-stage renal failure; VasoC, vasoconstrictors (Y, yes; N, no); GFR, glomerular filtration rate.

Feasibility
-----------

Although some of the scans were performed on haemodynamically unstable patients, all of them could be performed as per protocol. As an example, the scan on ICU admission was completed at a mean of 110 (SD 42) minutes after ICU admission. All scans were performed in less than half an hour (effective infusion time \<8 minutes for all patients).

Because of increased subcutaneous fluid and drains after the operation, adequate visualisation of the kidney was sometimes challenging. However, adequate contrast enhancement with contrast agent was obtained for all patients at all time points. At least one sequence for each study time point was judged by the two readers to be of adequate quality for interpretation. An illustration of destruction-refilling sequences obtained during the study is presented in Figure [1](#F1){ref-type="fig"}.

![**Illustration of destruction-reperfusion sequence**. During continuous infusion of the contrast agent, microbubble destruction is obtained by applying pulses at high mechanical index (high ultrasound intensity). Microcirculation replenishment is then observed. All images represent renal contrast-enhanced ultrasonography (CEUS), the left part of the image shows contrast-image mode imaging and the right part the standard (B-mode) image. (**a**) Immediately after the flash; (**b**) during replenishment (2 seconds after the flash); (**c**) at full replenishment (6 seconds after the flash); (**d**) sequence analysis with Sonotumor^®^: a region of interest was drawn (yellow line) in the largest possible area of renal cortex closer to the ultrasound probe. The software generates a time intensity curve. This curve is used to generate CEUS-derived parameters.](cc12817-1){#F1}

Tolerance
---------

Overall, 36 contrast-enhanced ultrasound examinations were performed using a total of 72 vials of Sonovue^®^(10 ml per scan). Of these, twenty-four were performed in the ICU, including nine examinations in patients requiring vasoconstrictors for severe hypotension. No adverse effect was noted. Haemodynamic characteristics of patients before and after CEUS are presented in Table [2](#T2){ref-type="table"}.

###### 

Safety data

  Measurement                                  Two hours pre   One hour pre    CEUS            One hour post   Two hours post   *P*-value
  -------------------------------------------- --------------- --------------- --------------- --------------- ---------------- -----------
  Cardiac index                                2.87 (0.62)     2.96 (0.46)     2.9 (0.45)      2.9 (0.58)      2.92 (0.48)      0.99
  Heart rate, beats per minute                 84.67 (15.56)   83.83 (15.01)   84 (12.48)      84.65 (14.62)   84.88 (15.08)    0.69
  Lactate, mmol/l                              1.73 (1.05)     1.56 (0.84)     1.43 (0.85)     1.81 (0.87)     1.62 (1.09)      0.72
  Mean arterial pressure, mmHg                 80.17 (15.24)   79.96 (10.14)   78.46 (9.62)    77.17 (11.24)   76.42 (10.4)     0.43
  Systolic pulmonary arterial pressure, mmHg   29.28 (15.13)   28.8 (14.17)    27.85 (14.12)   28.67 (14.74)   28.71 (15.47)    0.98
  Noradrenaline infusion rate, mcg/min         1.75 (2.83)     1.88 (2.83)     1.92 (3.59)     2.5 (4.6)       2.42 (4.6)       0.94
  Respiratory rate, breath per minute          15.26 (4.69)    14.96 (4.65)    16.04 (4.54)    14.83 (3.75)    15.14 (3.87)     0.39

Data are presented as mean (SD). CEUS, contrast-enhanced ultrasound.

Inter-observer agreement
------------------------

Correlation between readers was excellent for PI (*R*^2^= 0.96, *P*\< 0.0001) and for RBV (*R*^2^= 0.94, *P*\< 0.001) but only moderate for mTT (0.51, *P*\< 0.0001). Intra-class correlation was 0.69 (95% CI 0.5, 0.84) for PI, 0.68 (95% CI 0.48, 0.83) for RBV and 0.43 (95% CI 0.25, 0.63) for mTT.

As presented in Figure [2](#F2){ref-type="fig"}, agreement between readers was good. Mean bias for PI was -412 a.u. (6.9% of the mean value) with limits of agreement from -4,065 to 3,243 a.u. (± 61% of the mean value). For RBV, the mean bias was -1,320 (9.2% of the mean value) with limits of agreements from -5,670 to 3,030 (± 30.4% of the mean value). Similarly, for mTT the mean bias was -0.39 (9.1% of the mean value) with limits of agreements -7.8 to 7.1 (± 172% of the mean value).

![**Bland-Altman plot for inter-observer agreement (perfusion indices)**. a.u., arbitrary units.](cc12817-2){#F2}

CEUS-derived parameters
-----------------------

### Perfusion indices (PI)

Baseline PI values ranged from 1,069 to 29,446 a.u. Changes in such values indexed to baseline are presented in Figure [3](#F3){ref-type="fig"}. Compared with baseline, PI values decreased 24 hours after admission in nine patients. Pooled values for PI are presented in Figure [4](#F4){ref-type="fig"}. PI decreased from a baseline median value of 6,750 (2,042 to 8,263) to 3,936 (1,645 to 6,004) on ICU admission (-42%, *P*= 0.33) and to 3,308 (1,243 to 4,573) 24 hours later (-51%, *P*\< 0.01). After adjustment for mean arterial pressure, inotrope infusion and haemoglobin, there was no difference in PI between baseline and ICU admission (*P*= 0.70) but there was a significant decrease in PI 24 hours after admission (*P*= 0.03).

![**Perfusion indices: individual patients results indexed**.](cc12817-3){#F3}

![**Overall results for perfusion indices**.](cc12817-4){#F4}

### Relative blood volume (RBV)

Baseline RBV values ranged from 4,846 to 29,958 a.u. Compared with baseline, nine patients had lower RBV 24 hours after surgery. Pooled RBV decreased from 15,342 a.u. (IQR 7,862 to 20,490) on baseline to 13,113 a.u. (IQR 8,952 to 17,310) on ICU admission (-14%, p = 0.31) and to 11929 a.u. (IQR 6,312 to 15,904) 24 hours after admission (-22%, *P*= 0.09). After adjustment for mean arterial pressure, inotrope infusion and haemoglobin, there was no difference in RBV between baseline and ICU admission (*P*= 0.29) and a trend for a decrease 24 hours after admission (*P*= 0.11).

### Mean transit time (mTT)

Baseline mTT values ranged from 1.0 to 7.7 seconds. Compared with baseline, most (10/12) patients experienced an increase in their mTT 24 hours after the admission.

Pooled mTT increased from a median value of 2.9 seconds (IQR 2.1 to 3.3) on baseline to 3.3 (IQR 2.0 to 4.2) on ICU admission (+14%, *P*= 0.73) and to 4.3 (IQR 2.8 to 4.7) 24 hours later (+48%, *P*= 0.04). After adjustment for mean arterial pressure, inotrope infusion and haemoglobin, there was no difference in mTT between baseline and ICU admission (*P*= 0.15) or 24 hours after admission (*P*= 0.37).

Correlation with changes in creatinine levels
---------------------------------------------

Four patients developed AKI (risk, injury, failure, loss, end-stage renal failure (RIFLE)-R in three and RIFLE-I in one patient) but none required RRT. There was no correlation between changes in PI in the first 24 hours after cardiac surgery and changes in serum creatinine levels.

Discussion
==========

Key findings
------------

Using CEUS we were able to quantify changes in the microcirculation of the renal cortex before and after cardiac surgery in 12 patients deemed at risk of AKI. In these patients we performed 36 CEUS scans, including 24 in the ICU. Such studies were all performed in less than half an hour and did not interfere with clinical management. Tolerance was excellent and no adverse effect was noted. When compared with baseline, we found no overall difference in CEUS-derived parameters (PI, RBV and mTT) on ICU admission. However, 24 hours after the operation, there was an overall 50% decrease in the PI, suggestive of decreased renal cortical perfusion.

Comparison with previous studies
--------------------------------

The general safety of CEUS has been demonstrated in several large retrospective studies \[[@B19]-[@B21]\], one of which included critically ill patients \[[@B21]\]. The reported rates of adverse events, including potentially severe anaphylactoid reactions or complement activation-related pseudo-allergy (CARPA) \[[@B22]\], are in the range of 1 per 10,000 administrations. There are, however, no detailed data on CEUS safety after cardiopulmonary bypass, or during mechanical ventilation or vasoconstrictor administration. Our study provides such information. In addition, we were able to report the absence of changes in systolic pulmonary pressure after contrast-agent administration. This is consistent with previous findings \[[@B23]\] in patients undergoing right heart catheterization with Definity^®^as a contrast agent. Our data confirm the absence of measurable physiological changes even in haemodynamically unstable patients during administration of Sonovue^®^for CEUS.

In a previous study \[[@B24]\], we evaluated the ability of CEUS to detect changes in renal cortical perfusion in healthy volunteers. We found that CEUS was able to detect a 15% change in renal flow as induced by angiotensin II or captopril administration. These results were consistent with those found by Kishimoto *et al*. \[[@B25]\] using a different technique. However, to the best of our knowledge, there has not been any previous attempt to use CEUS for quantification of renal perfusion in patients undergoing cardiac surgery, hence our findings are novel and cannot be compared with previous data. Estimates of global renal blood flow have been obtained with the measurement of para-immuno hippurate clearance corrected by renal vein sampling \[[@B26]\]. This technique requires the insertion of an 8-Fr catheter into the left renal vein under fluoroscopic guidance. Using this invasive strategy, authors have demonstrated, in similar patients, the potential of noradrenaline to improve oxygen delivery, glomerular filtration rate (GFR) and the renal oxygen supply/demand relationship in cardiac surgery patients with vasodilatory shock and AKI \[[@B27]\], as well as an increase in RBF induced by mannitol \[[@B28]\] or dopamine \[[@B29]\]. The lack of correlation between estimate of flow and function is consistent with data obtained with cine-phase contrast magnetic resonance imaging (MRI) \[[@B30]\].

Clinical significance
---------------------

Our pilot study supports the feasibility and safety of CEUS at the bedside in the ICU, in particular in the period around cardiac surgery, even in patients deemed at risk of AKI. Despite some relative haemodynamic instability, adequate visualisation of the kidney was feasible in all cases. The finding of decreased cortical perfusion at 24 hours is plausible and consistent with previous findings \[[@B30]\]. This study, together with larger safety studies, establishes CEUS as a fast, safe and feasible procedure in critically ill patients. Larger studies are required to confirm or refute the decrease in renal cortical perfusion after cardiac surgery suggested by our results.

Strength and limitations
------------------------

To the best of our knowledge, this study is the first to report non-invasive, real-time measurement of renal cortical microcirculation in humans before and after cardiac surgery. In addition, it has several strengths. Extensive invasive monitoring was available for all patients in the post-operative period, enabling detection of subclinical adverse events. All scans were performed by a single operator (AS) and were analysed by two senior radiologists blinded to patient and time. This enabled evaluation of inter-observer agreement. Despite important baseline heterogeneity, a statistically significant decrease in renal cortical perfusion was detected with a sample size as small as 12 patients.

On the other hand, this study has several limitations. First, CEUS parameters could not be correlated to a comparator/gold standard. Indeed, such measurements of the microcirculation are novel and no gold standard has emerged. Comparison with macrocirculation using techniques such as PAH clearance or MRI would have been theoretically possible but logistically very complicated or invasive and could not occur simultaneously. In addition, such comparison would be informative at best, but could also potentially be misleading, as the correlation between macro- and microcirculation is not necessarily linear.

There was important heterogeneity in individual results and baseline perfusion indices. However, such heterogeneity was not likely to arise from interpretation errors, as illustrated by the good agreement between the readers. Similar heterogeneity in baseline measurements was found in our previous study in healthy subjects \[[@B24]\]. It is more likely to be associated with different patient properties, such as depth of organ, thickness of subcutaneous tissue and the renal capsule or other properties influencing ultrasound beam attenuation. This is consistent with the greater variability observed in the RBV component, which is more sensitive to attenuation (as it is a measure of the intensity of the ultrasound signal). The mTT component, which is the time to replenishment, could be a more robust measure. However, this heterogeneity should not have influenced the validity of our results, as only changes in values from baseline in identical patients were considered. Decreased renal perfusion was not found in all patients. However, patients had different clinical courses and heterogeneity would be expected, given the differences in age, type of operation and duration of bypass.

We did not find a correlation between CEUS indices and impairment of renal function; however, given the small number of patients, this needs to be confirmed in larger studies. Finally, we were not able to report on medullary perfusion. Indeed, such a parameter together with cortico-medullary perfusion ratios of CEUS parameters would be of great interest. However, medullary perfusion was not measurable with adequate reproducibility using our current technology.

Future studies
--------------

Further studies are required to confirm or refute these results. In particular, due to the limited number of patients included in this study, we were not able to draw any conclusion about correlation of changes in CEUS-derived indices and clinical outcomes such as AKI, need for RRT or mortality.

Conclusions
===========

CEUS is feasible and well-tolerated in patients undergoing cardiac surgery, in particular immediately after ICU admission. CEUS-derived parameters suggest a decrease in renal perfusion occurring within 24 hours of surgery. Further studies with larger sample size are required to establish whether there is a correlation between changes in microvascular cortical flow and markers of renal function.

Key messages
============

• CEUS is safe and feasible in critically ill patients and in particular during the cardiac surgery peri-operative period.

• In patients at risk of AKI, CEUS-derived parameters suggest a decrease in renal cortical perfusion in the 24 hours following cardiac surgery.
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